Collagen-Localized Immunomodulatory Molecules for Cancer Immunotherapy
Exclusively Licensed
Invention type: Technology
/
Case number: #20867
The present disclosure provides immunomodulatory fusion proteins comprising a collagen-binding domain operably linked to an immunomodulatory domain. The disclosure also features compositions and methods of using the same, for example, to treat cancer.
Researchers
Karl Dane Wittrup
/
Magnolia Chinn
/
Allison Sheen
/
Joseph Palmeri
/
Noor Momin
Departments: Department of Chemical Engineering
Technology Areas: Biotechnology: Biomanufacturing, Synthetic Biology / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living
-
collagen-localized immunomodulatory molecules and methods thereof
Hong Kong | Published application -
collagen-localized immunomodulatory molecules and methods thereof
Singapore | Pending -
collagen-localized immunomodulatory molecules and methods thereof
United States of America | Pending -
collagen-localized immunomodulatory molecules and methods thereof
Japan | Granted | 7,557,882 -
collagen-localized immunomodulatory molecules and methods thereof
Canada | Published application -
collagen-localized immunomodulatory molecules and methods thereof
China | Published application -
collagen-localized immunomodulatory molecules and methods thereof
Australia | Granted | 2,019,346,335 -
collagen-localized immunomodulatory molecules and methods thereof
Brazil | Pending -
collagen-localized immunomodulatory molecules and methods thereof
Israel | Pending -
collagen-localized immunomodulatory molecules and methods thereof
India | Published application -
collagen-localized immunomodulatory molecules and methods thereof
Korea (south) | Published application -
collagen-localized immunomodulatory molecules and methods thereof
Singapore | Pending -
collagen-localized immunomodulatory molecules and methods thereof
European Patent Convention | Published application -
collagen-localized immunomodulatory molecules and methods thereof
Mexico | Pending -
collagen-localized immunomodulatory molecules and methods thereof
United States of America | Granted | 12,227,559
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.